Clofibric acid is a peroxysome proliferator-activated receptor α (PPARα) ligand that reduces PGE2 levels, leading to repression of VEGF expression, inhibition of angiogenesis and tumor cell apoptosis in a preclinical ovarian cancer model [110]. This evidence concerns the gene VEGFA and neoplasm.